The Value in Tool Companies

Most investments in genomics and other life science information companies didn't work. Tool companies--those that sell instruments for discovery research--can make successful investments, but they require a clear agreement up-front on the exit strategy: acquisition.

Q: Most investments in genomics and other life science information companies didn't work. What about tool companies--those that sell instruments to pharmaceutical and biotech companies to help with discovery research or clinical development?

A: On its face, investing in life science instrumentation companies is a sound strategy. Instrument companies share a number of the favorable attributes associated with investments in medical device companies:...

More from R&D

More from Scrip